Document Detail


Soft agarose colony formation assay for human renal cell carcinoma: comparison of optical colony counting versus tritiated thymidine incorporation.
MedLine Citation:
PMID:  3773078     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Use of the Hamburger-Salmon soft agar assay method for in vitro chemotherapy sensitivity testing of samples of renal cell carcinoma has been somewhat limited by a relatively low proliferation/evaluability rate for this tumor type (approximately 50%). The tritiated thymidine ([ 3H]-TdR) incorporation assay method of Tanigawa et al. (Cancer Res., 42: 2159, 1982) was compared to a standard optical colony counting assay technique. Fifty-seven different primary and five metastatic fresh samples of human renal cell carcinoma were studied. Evaluability rate by the [3H]-TdR assay was 90% (greater than or equal to 300 cpm control). In comparison, evaluability rate by optical colony counting was 43% for this group of tumors. [3H]-TdR incorporation increased with increasing tumor grade and increasing stage. Spindle cell tumors showed significantly higher cpm than other cell types. Twenty-three primary tumors were evaluable by both [3H]-TdR and colony counting methods. The correlation coefficient ("r") for regression lines for drug sensitivity data points (optical counting vs. [3H]-TdR) of these individual experiments ranged from 0.50 to 0.99 with a mean r +/- S.D. of 0.76 +/- 0.15. For all 260 paired drug response observations of 23 tumors exposed to different drugs, the correlation was very good with r = 0.71. Since the [3H]-TdR assay has an evaluability rate of approximately 90% for renal cell carcinoma, gives drug sensitivity information which correlates well with the colony counting endpoint and yields chemotherapy sensitivity information four days after sample accession, the [3H]-TdR assay may be a more useful method for study of human renal cell carcinoma in vitro chemotherapy sensitivity testing than standard colony counting techniques.
Authors:
Y Hosaka; T Tsukamoto; M M Lieber
Related Documents :
10096558 - A novel, orally administered nucleoside analogue, ogt 719, inhibits the liver invasive ...
18507058 - Detection of cell-free ercc1 and thymidylate synthase (ts) mrna in malignant effusions ...
24473088 - Glioblastoma multiforme: a look inside its heterogeneous nature.
21378208 - Neurooncology.
18668518 - Simultaneous occurrence of right adrenocortical tumor and left adrenal neuroblastoma in...
2931598 - Effect of nonspecific immune stimulation with bcg and polidin on the ehrlich ascites tu...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  The Journal of urology     Volume:  136     ISSN:  0022-5347     ISO Abbreviation:  J. Urol.     Publication Date:  1986 Nov 
Date Detail:
Created Date:  1986-11-24     Completed Date:  1986-11-24     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0376374     Medline TA:  J Urol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1102-9     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antineoplastic Agents / pharmacology
Carcinoma, Renal Cell / pathology*
Cell Count
Colony-Forming Units Assay*
Humans
Kidney / pathology
Kidney Neoplasms / pathology*
Neoplastic Stem Cells / drug effects
Sepharose
Thymidine / diagnostic use
Tritium
Tumor Stem Cell Assay*
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 10028-17-8/Tritium; 50-89-5/Thymidine; 9012-36-6/Sepharose

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Female pseudohermaphroditism in a neonate born to a mother with polycystic ovarian disease.
Next Document:  Detrusor collagen content in the denervated rat urinary bladder.